NasdaqCM - Nasdaq Real Time Price ? USD Movano Inc. (MOVE) Follow Compare 0.2632 -0.0328 (-11.08%) At close: October 25 at 4:00 PM EDT 0.2599 -0.00 (-1.25%) After hours: October 25 at 7:55 PM EDT All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations Movano Health Announces Reverse Stock Split Movano Health (Nasdaq: MOVE) announced today that it will implement a 1-for-15 reverse stock split of the issued shares of its common stock (the "Reverse Stock Split"), effective at 12:01 a.m. Eastern time on October 29, 2024. The Company's common stock is expected to begin trading on a split-adjusted basis when the market opens on Tuesday, October 29, 2024, and will continue to trade on The Nasdaq Capital Market under the symbol "MOVE." The new CUSIP number for the common stock will be 62459M 2 PR Newswire ? yesterday MOVE -11.08% Movano Health Plans Response Submission to FDA Next Week as Part of EvieMED Final Review Phase Movano Health (Nasdaq: MOVE) announced today that it plans to submit updated responses next week to all clarifying questions that it recently received from the FDA as part of the final phase of the Company's 510(k) application review. The Company secured a positive resolution this summer after responding to initial FDA questions related to EvieMED's wellness features and metrics and remains optimistic on EvieMED's potential for 510(k) clearance. PR Newswire ? 2 days ago MOVE -11.08% Movano Health Provides Update on FDA Review of EvieMED Ring Movano Health (Nasdaq: MOVE) announced today that the Company recently received additional clarifying questions from the FDA related to medical aspects of the EvieMED Ring, as part of the final phase of the Company's 510(k) application review process. The Company secured a positive resolution this summer after responding to initial FDA questions related to EvieMED's wellness features and metrics and remains optimistic on EvieMED's potential for 510(k) clearance. PR Newswire ? 16 days ago MOVE -11.08% Evie, Movano Health's Smart Ring for Women, is Back In Stock with Key Upgrades Movano Health (Nasdaq: MOVE) today announced the immediate availability of its Evie Ring, the first smart ring designed specifically for women. The ring features the same industry-first, award-winning open design that accommodates fluctuations in finger size, and is accompanied by an updated app that enhances users' ability to track and understand key metrics vital to their health and wellness. PR Newswire ? last month MOVE -11.08% Movano Health Advances to Final Phase of FDA Review Process for EvieMED Ring Movano Health (Nasdaq: MOVE) announced today that a productive in-person meeting with the FDA on August 15, 2024, resulted in a positive outcome regarding the EvieMED Ring's wellness features and metrics. Following this development, the Company will be working with the agency to move forward with the review process. The EvieMED Ring is a wearable device designed to not only provide medical device functionality through its pulse oximetry feature, but also offer numerous wellness metrics related t PR Newswire ? last month MOVE -11.08% Movano (NASDAQ:MOVE) Will Have To Spend Its Cash Wisely There's no doubt that money can be made by owning shares of unprofitable businesses. For example, biotech and mining... Simply Wall St. ? 2 months ago MOVE -11.08% Movano Health Reports Q2 2024 Financial Results and Provides Business Update Movano Health (Nasdaq: MOVE), a pioneer in health technology, reported second quarter 2024 results and provided a business update. PR Newswire ? 2 months ago MOVE -11.08% Movano Health to Report Second Quarter 2024 Financial Results on Wednesday August 14, 2024 Movano Health (Nasdaq: MOVE), a pioneer in health technology, today announced that it will report second quarter 2024 financial and operating results on Wednesday, August 14, 2024, after the market close. Management will host a conference call and live audio webcast to discuss these results and provide a business update on the same day at 2:00 pm PT/5:00 pm ET. PR Newswire ? 2 months ago MOVE -11.08% Movano Health Provides Progress Update on EvieMED Regulatory Filing Movano Health (Nasdaq: MOVE) plans to meet with the FDA in mid-August, as part of the Company's ongoing process to secure a 510(k) clearance for the EvieMED Ring, a wearable designed to not only provide medical device functionality through its pulse oximetry feature, but also offer numerous wellness metrics related to sleep, activity and mood/energy/symptom logging. On April 21, 2024, Movano Health filed an updated 510(k) for the EvieMED Ring's pulse oximetry feature. At the time of the filing a PR Newswire ? 2 months ago MOVE -11.08% Movano Health Announces Dr. Fatima Rodriguez Joining July 11 Virtual Event Movano Health (Nasdaq: MOVE) announced the addition of two expert participants to its B2B: The Next Wearables Boom Virtual Event to be held on July 11 – Dr. Fatima Rodriguez and Matt Hughes. PR Newswire ? 3 months ago MOVE -11.08% Movano Health Applies Advanced AI through Deep Learning to Deliver Improved Accuracy of Heart Rate in Motion Movano Health (Nasdaq: MOVE) announced major advances in the accuracy of its heart rate in motion algorithm following the implementation of deep learning into the processing. The Company recently released an engineering accuracy study directed by Movano Health Founder and CTO Michael Leabman, Enhanced Heart Rate in Motion Accuracy with the Evie Ring Using Advanced Deep Learning Algorithms, which demonstrates the value of deep learning integration into heart rate (HR) algorithms for improved accu PR Newswire ? 4 months ago MOVE -11.08% MIT Selects Movano Health for Groundbreaking Study on Long COVID and Chronic Lyme Disease In a strategic move that could reshape the understanding of long COVID and chronic Lyme disease, the Massachusetts Institute of Technology (MIT) has forged a partnership with Movano Health for its MAESTRO study to harness the medical grade continuous health monitoring capabilities of Movano's Evie Ring. PR Newswire ? 4 months ago MOVE -11.08% Movano Health Reports Q1 2024 Financial Results and Provides Business Update Movano Health (Nasdaq: MOVE), a pioneer in health technology, reported first quarter 2024 results and provided a business update. PR Newswire ? 5 months ago MOVE -11.08% Movano Health Submits Exemplary Sp02 Clinical Trial Results in Key Step Towards FDA 510(k) Clearance Decision Movano Health (Nasdaq: MOVE) announced that it successfully submitted updated pivotal clinical trial results as well as proof of enhanced medical device usability on April 22, 2024 to the U.S. Food and Drug Administration (FDA) as part of its 510(k) filing for the Company's first commercial medical device, the Evie Med Ring pulse oximeter. An FDA clearance would bring Movano Health a significant step closer in its pursuit to disrupt the wearables industry while unlocking significant partnership PR Newswire ? 5 months ago MOVE -11.08% Movano Health to Report First Quarter 2024 Financial Results on Wednesday May 15, 2024 Movano Health (Nasdaq: MOVE), a pioneer in health technology, today announced that it will report first quarter 2024 financial and operating results on Wednesday May 15, 2024, after the market close. Management will host a conference call and live audio webcast to discuss these results and provide a business update on the same day at 2:00 pm PT/5:00 pm ET. PR Newswire ? 5 months ago MOVE -11.08% Movano Health Closes $24 Million Private Placement Movano Health (Nasdaq: MOVE), a pioneer in health technology, has closed on a $24.1 million private placement, totaling 45.3 million units, with each unit consisting of one share of the Company's common stock (or pre-funded warrant in lieu thereof) and one warrant to purchase a share of common stock, to a select group of investors that includes a tier-one multi-billion dollar medical device company, institutional and accredited investors, and members of the Company's management team and board of PR Newswire ? 6 months ago MOVE -11.08% Movano Health Reports 2023 Financial Results and Provides Business Update Movano Health (Nasdaq: MOVE), a pioneer in health technology, reported fourth quarter and year end 2023 results and provided a business update. PR Newswire ? 6 months ago MOVE -11.08% Movano Health Announces $24 Million Private Placement Movano Health (Nasdaq: MOVE), a pioneer in health technology, today has agreed to sell approximately 45 million units in a $24 million private placement, with each unit consisting of one share of the Company's common stock (or pre-funded warrant in lieu thereof) and one warrant to purchase a share of common stock, to a select group of investors that includes a tier-one multi-billion dollar medical device company, institutional and accredited investors, and members of the Company's management tea PR Newswire ? 6 months ago MOVE -11.08% Movano Health Secures Strategic Investment from Tier-One Multi-Billion Dollar Medical Device Company Movano Health (Nasdaq: MOVE), a pioneer in health technology, secured a strategic investment from a tier-one multi-billion dollar medical device company and signed an agreement to explore future collaborations relating to development and commercialization. PR Newswire ? 6 months ago MOVE -11.08% Movano Health to Report Fourth Quarter 2023 Financial Results on Thursday, April 4, 2024 Movano Health (Nasdaq: MOVE), a pioneer in health technology, today announced that it will report fourth quarter 2023 financial and operating results on Thursday, April 4, 2024, after the market close. Management will host a conference call and live audio webcast to discuss these results and provide a business update on the same day at 2:00 pm PT/5:00 pm ET. PR Newswire ? 6 months ago MOVE -11.08% Performance Overview Trailing total returns as of 10/25/2024, which may include dividends or other distributions. Benchmark is S&P 500 Return MOVE S&P 500 YTD -66.30% +21.77% 1-Year -69.75% +36.74% 3-Year -91.64% +27.79%
